| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 9e-06 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |